Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001493152-26-013287
Filing Date
2026-03-27
Accepted
2026-03-27 17:24:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM formposam.htm POS AM 410706
2 EX-23.1 ex23-1.htm EX-23.1 3970
3 GRAPHIC formposam_001.jpg GRAPHIC 7647
  Complete submission text file 0001493152-26-013287.txt   426342
Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Filer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-293950 | Film No.: 26808684
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)